BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3124996)

  • 1. Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.
    Calder VL; Bellamy AS; Owen S; Lewis C; Rudge P; Davison AN; Feldmann M
    Clin Exp Immunol; 1987 Dec; 70(3):570-7. PubMed ID: 3124996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
    Reed JC; Abidi AH; Alpers JD; Hoover RG; Robb RJ; Nowell PC
    J Immunol; 1986 Jul; 137(1):150-4. PubMed ID: 3011905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus.
    Kasaian MT; Biron CA
    J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
    Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
    J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.
    Granelli-Piperno A; Keane M; Steinman RM
    Transplantation; 1988 Aug; 46(2 Suppl):53S-60S. PubMed ID: 3136567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis.
    Kermani-Arab V; Salehmoghaddam S; Danovitch G; Hirji K; Rezai A
    Transplantation; 1985 Apr; 39(4):439-42. PubMed ID: 3920796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS; Calder VL; Feldmann M; Davison AN
    Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody inhibiting leucocyte adhesion blocks induction of IL-2 production but not IL-2 receptor expression.
    Lindqvist C; Patarroyo M; Beatty PG; Wigzell H
    Immunology; 1987 Apr; 60(4):579-84. PubMed ID: 3108139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down regulation of IL 2 mRNA by antibody to the 50-kd protein associated with E receptors on human T lymphocyte.
    Tadmori W; Kant JA; Kamoun M
    J Immunol; 1986 Feb; 136(4):1155-60. PubMed ID: 3484763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation.
    Aiello FB; Maggiano N; Larocca LM; Piantelli M; Musiani P
    Cell Immunol; 1986 Jan; 97(1):131-9. PubMed ID: 3091267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin.
    Warren HS; Bezos A
    Immunology; 1987 Jun; 61(2):167-72. PubMed ID: 3496271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.